1. <rp id="4ug6k"><object id="4ug6k"><blockquote id="4ug6k"></blockquote></object></rp>
          <dd id="4ug6k"></dd>

            <em id="4ug6k"><object id="4ug6k"><input id="4ug6k"></input></object></em>
              Profile Core value Main business Legitimacy Social Responsibility
                Patents Research Direction Technology Strength
              API Intermediates Side chain for Paclitaxel and Docetaxel N-1 stage
              Production management QC Quality System branch factory




              Products Center
            Paclitaxel (Semi-synthetic)
            Paclitaxel (Natural)
            Docetaxel Anhydrous
            Docetaxel Trihydrate
            Irinotecan HCl Trihydrate 99.5%
            Etoposide USP31
            Palonosetron Hydrochloride
              N-1 stage of Paclitaxel and Docetaxel
              Main Intermediates
            10-Deacetylbaccatin III
            Baccatin III
              Side chain for Paclixel semi-Synthetic
            (4S,5R)-3-(N-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
              Side chain of Docetaxel
            (4S,5R)-3-(N-tert-butoxycarbony)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
              Side chain for Paclitaxel and Docetaxel
            Ethyl (2R,3S)-3-Phenylisoserine Ester
              About us   more  

            Shanghai Jinhe Bio-Pharmaceutical Co., Ltd. (Abrr. "Jinhe") , founded in March 2002, is a pharmaceutical enterprise dedicated to R & D, manufacturing and marketing anti-cancer APIs and their intermediates. Based on the R&D achievement of Fudan University, we began to undertake the international business of processing Paclitaxel API. After years of effort, we successfully developed Paclitaxel, Docetaxel, Irinotecan, Etoposide etc, from natural extracting anti-cancer products into material source anti-cancer APIs. In recent years, we developed new APIs, such as Cabazitaxel, Palonosetron hydrochloride etc. In 2012, we cooperated with Shanghai Zhongxi Sunve Pharmaceutical Co.,Ltd, (Abrr. "Sunve") became a member of Shanghai Pharmaceuticals Holding Co.,Ltd. (Abrr. "SPH"). Since then, we targeted ourselves as the production base of SPH on oncology products....

              News   more  
              Shanghai Jinhe Bio-Technology Co.,Ltd. was renamed Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd.  
              Warmly celebrate Shanghai Jinbe Bio-Pharmaceutical Co., Ltd new GMP factory officially put into operation. It marked the transition from Chemical plant to the Pharmaceutical factory.  
              Our company's booth on API CHINA & INTERPHEX CHINA 2013, NO.: 3BE56  
              Welcome to our ... booth on CPHI, ICSE & BioPh China 2013, NO.: W1B12  
              Welcome to our ... CPHI Worldwide 2013 (Frankfurt, Germany), NO.: 31E12  
              Welcome to our company's booth on CPHI INDIA 2013, NO.: D16 in Hall 1  
              Welcome to our company’s booth on CPHI & ICSE INDIA 2012, NO.:D16 ...  
              We will participate in CPHI & ICSE China 2012during June 26-28, 2012...  
              Welcome to visit us at our booth: A66 during CPHI Japan 2012.  
              Welcome to visit us at our booth: BK02 during API 67-2011 Nanjing.  
              Contact us
                Shanghai Jinhe Bio-Pharmaceutical Co., Ltd.

            Market Development (International)
            Contact: Chen Miaochang
            Direct: 86-21-51915568
            Mobile: 86-13816742275

            Sale (International)
            Contact: Chen Miaochang
            Direct: +86- 21-59811408
            Mobile : +86- 13816742275
            E-mail: chenmiaochang@zhongxijinhe.com; sales@biotaxu.com

            URL: http://www.hewadgroup.com


            Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd. CopyRight(C)2006 All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice ChemNet
            HOME About us Products R & D Production and QA Contact us CHINESE